Windlas Biotech Limited (WINDLAS.NS)

INR 1050.0

(-0.63%)

Long Term Debt Summary of Windlas Biotech Limited

  • Windlas Biotech Limited's latest annual long term debt in 2023 was 20.18 Million INR , down -35.44% from previous year.
  • Windlas Biotech Limited's latest quarterly long term debt in 2024 Q1 was - INR , down 0.0% from previous quarter.
  • Windlas Biotech Limited reported annual long term debt of 31.26 Million INR in 2022, up 604.05% from previous year.
  • Windlas Biotech Limited reported annual long term debt of 4.44 Million INR in 2021, down -67.09% from previous year.
  • Windlas Biotech Limited reported quarterly long term debt of 20.18 Million INR for 2023 FY, down -35.44% from previous quarter.
  • Windlas Biotech Limited reported quarterly long term debt of 25.55 Million INR for 2023 Q2, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Windlas Biotech Limited (2023 - 2017)

Historical Annual Long Term Debt of Windlas Biotech Limited (2023 - 2017)

Year Long Term Debt Long Term Debt Growth
2023 20.18 Million INR -35.44%
2022 31.26 Million INR 604.05%
2021 4.44 Million INR -67.09%
2020 13.49 Million INR -39.94%
2019 22.46 Million INR -69.32%
2018 73.21 Million INR -59.63%
2017 181.36 Million INR 0.0%

Peer Long Term Debt Comparison of Windlas Biotech Limited

Name Long Term Debt Long Term Debt Difference
Sigachi Industries Limited 265.79 Million INR 92.408%
Ind-Swift Limited 10.09 Billion INR 99.8%
Bajaj HealthCare Limited 650.34 Million INR 96.897%
Sakar Healthcare Limited 549.55 Million INR 96.328%
Aurobindo Pharma Limited 21.34 Billion INR 99.905%
Innova Captab Limited 2.1 Billion INR 99.041%
Divi's Laboratories Limited 20 Million INR -0.9%
AstraZeneca Pharma India Limited 27.83 Million INR 27.504%
Morepen Laboratories Limited 33.64 Million INR 40.012%
Mankind Pharma Limited 325.81 Million INR 93.806%
Sequent Scientific Limited 1.42 Billion INR 98.586%
Wanbury Limited 820 Million INR 97.539%
Laurus Labs Limited 7.98 Billion INR 99.747%
Nectar Lifesciences Limited 1.4 Billion INR 98.562%
Glenmark Life Sciences Limited 147.61 Million INR 86.329%
Alembic Limited 73.9 Million INR 72.693%
Hikal Limited 4.22 Billion INR 99.523%
Alembic Pharmaceuticals Limited 628.8 Million INR 96.791%
Neuland Laboratories Limited 449.2 Million INR 95.508%
J. B. Chemicals & Pharmaceuticals Limited 236.4 Million INR 91.464%
Glenmark Pharmaceuticals Limited 1.51 Billion INR 98.67%
IOL Chemicals and Pharmaceuticals Limited - INR -Infinity%
Themis Medicare Limited 267.74 Million INR 92.463%
RPG Life Sciences Limited -30.3 Million INR 166.601%
Zydus Lifesciences Limited 251 Million INR 91.96%
Lupin Limited 1.55 Billion INR 98.7%
Amrutanjan Health Care Limited 13.96 Million INR -44.473%
Wockhardt Limited 8.91 Billion INR 99.774%
Vaishali Pharma Limited 35.98 Million INR 43.918%
Aarti Pharmalabs Limited 400 Thousand INR -4945.0%
Jagsonpal Pharmaceuticals Limited 75.57 Million INR 73.296%
Jubilant Pharmova Limited 31.67 Billion INR 99.936%
FDC Limited 2.46 Million INR -718.329%
Dr. Reddy's Laboratories Limited 5.99 Billion INR 99.663%
Kilitch Drugs (India) Limited - INR -Infinity%
Eris Lifesciences Limited 6.54 Billion INR 99.692%
Venus Remedies Limited 386.8 Million INR 94.783%
ZIM Laboratories Limited 356 Million INR 94.332%
Bliss GVS Pharma Limited 355.92 Million INR 94.33%
Par Drugs and Chemicals Limited - INR -Infinity%
Caplin Point Laboratories Limited 9.2 Million INR -119.348%
Shilpa Medicare Limited 5.6 Billion INR 99.64%
Albert David Limited 6.01 Million INR -235.439%
Ajanta Pharma Limited 235.2 Million INR 91.42%
Hester Biosciences Limited 1.81 Billion INR 98.89%
Suven Pharmaceuticals Limited 212.35 Million INR 90.497%
Solara Active Pharma Sciences Limited 1.17 Billion INR 98.282%
Gufic Biosciences Limited 1.53 Billion INR 98.689%
Procter & Gamble Health Limited 68.8 Million INR 70.669%
Aarey Drugs & Pharmaceuticals Limited 32.24 Million INR 37.414%
Mangalam Drugs & Organics Limited 133.54 Million INR 84.889%
Granules India Limited 689.71 Million INR 97.074%
Aarti Drugs Limited 2.75 Billion INR 99.267%
Bal Pharma Limited 363.82 Million INR 94.453%
Alkem Laboratories Limited 400 Million INR 94.955%
Sun Pharmaceutical Industries Limited 13.3 Million INR -51.729%
Lincoln Pharmaceuticals Limited - INR -Infinity%
Medicamen Biotech Limited 12.55 Million INR -60.733%
Unichem Laboratories Limited 382.22 Million INR 94.72%
Bafna Pharmaceuticals Limited 107.53 Million INR 81.233%
Biofil Chemicals and Pharmaceuticals Limited - INR -Infinity%
Valiant Laboratories Limited 750.89 Million INR 97.313%
Orchid Pharma Limited 1.2 Billion INR 98.324%
Medico Remedies Limited 8.67 Million INR -132.703%
Ind-Swift Laboratories Limited 111.62 Million INR 81.922%
Ipca Laboratories Limited 5.8 Billion INR 99.652%
Brooks Laboratories Limited 3.56 Million INR -466.059%
Syncom Formulations (India) Limited -1.21 Million INR 1755.455%
Piramal Enterprises Limited 535.85 Billion INR 99.996%
Torrent Pharmaceuticals Limited 16.04 Billion INR 99.874%
NATCO Pharma Limited 53 Million INR 61.925%
Suven Life Sciences Limited - INR -Infinity%
Krebs Biochemicals & Industries Limited 1.83 Billion INR 98.9%
Strides Pharma Science Limited 6.71 Billion INR 99.699%
Indoco Remedies Limited 3.51 Billion INR 99.426%
Alpa Laboratories Limited - INR -Infinity%
Lasa Supergenerics Limited - INR -Infinity%
Sun Pharma Advanced Research Company Limited 106.6 Million INR 81.069%